WITHDRAWAL OF LONG-TERM ANTIHYPERURICEMIC THERAPY IN TOPHACEOUS GOUT

被引：17
|
作者：
GAST, LF
机构：
来源：
CLINICAL RHEUMATOLOGY | 1987年 / 6卷 / 01期
关键词：
D O I：
10.1007/BF02201004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：70 / 73
页数：4
相关论文
共 50 条
  • [21] AGOMELATINE AS ADJUNCTIVE THERAPY IN DISCONTINUATION OF LONG-TERM BENZODIAZEPINE WITHDRAWAL
    Mueller, H.
    Schuetz, P.
    Maler, J. M.
    Kornhuber, J.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [22] LONG-TERM MANAGEMENT OF GOUT AND HYPERURICEMIA
    SCOTT, JT
    BRITISH MEDICAL JOURNAL, 1980, 281 (6249): : 1164 - 1166
  • [23] Crystal arthritis: Combination therapy effective in tophaceous gout
    Ummarino D.
    Nature Reviews Rheumatology, 2017, 13 (8) : 450 - 450
  • [24] Follow-up study of Influence of antihyperuricemic therapy on primary gout
    China Medical Abstracts (Internal Medicine), 1996, (04) : 200 - 201
  • [25] Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone
    Ferrari, Serge
    Langdahl, Bente
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (05) : 307 - 317
  • [26] Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension
    Kim, NH
    Channick, RN
    Rubin, LJ
    CHEST, 2003, 124 (04) : 1612 - 1615
  • [27] Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone
    Serge Ferrari
    Bente Langdahl
    Nature Reviews Rheumatology, 2023, 19 : 307 - 317
  • [28] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy
    Colao, Annamaria
    Di Sarno, Antonella
    Guerra, Ermelinda
    Pivonello, Rosario
    Cappabianca, Paolo
    Caranci, Ferdinando
    Elefante, Andrea
    Cavallo, Luigi M.
    Briganti, Francesco
    Cirillo, Sossio
    Lombardi, Gaetano
    CLINICAL ENDOCRINOLOGY, 2007, 67 (03) : 426 - 433
  • [30] Recurrence of Hyperprolactinemia After Withdrawal of Long-Term Cabergoline Therapy COMMENT
    Kharlip, J.
    Salvatori, R.
    Yenokyan, G.
    Wand, G. S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2010, 65 (01) : 28 - 29
12345